Dailypharm Live Search Close

Results of HIRA¡¯s preemptive response to COVID-19

By Lee, Hye-Kyung | translator Alice Kang

21.04.26 17:27:37

°¡³ª´Ù¶ó 0
Support preventive measures against COVID-19 by providing epidemiological surveys and an identification system for repeated mask purchases

Completed developing a management system for treatments including remdesivir, legdanbimab, etc.



In the ¡®2020 sustainable management report¡¯ published by the Health Insurance Review and Assessment Service (HIRA), the institution cited its preemptive COVID-19 response as one of its achievements last year.

HIRA, which had organized a COVID-19 Countermeasure Promotion Committee in response to the COVID-19 pandemic, evaluated its performance to conclude that it had monitored 68,652 cases of international arrivals, sold 2.5 trillion won's worth of K-diagnostic agents as exports to 170 countries and supported 939.9 billion won in compensation to hospitals and small businesses impacted with COVID-19.

In particular, the 'identification system for repeated mask purchases¡¯ played a

Lee, Hye-Kyung(hgrace7@dailypharm.com)
If you want to see the full article, please JOIN US (click)